PTHS (STOCKS)
Pelthos Therapeutics Inc.
$23.000000
+0.000000 (+0.00%)
Prev close: $23.000000
Company Information
- Exchange
- XASE
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Scott M. Plesha
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $77.18M
- Employees
- 11
- P/E (TTM)
- -1.11
- P/B (TTM)
- 1.91
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
8
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-2.03 | $-4.21 | +2.1826 | +51.81% |
|
Sep 2025 (Q3)
|
$-5.30 | $-0.44 | -4.8614 | -1,108.39% |
|
Jun 2025 (Q2)
|
$-5.38 | $-6.39 | +1.0052 | +15.74% |
|
Dec 2024 (Q4)
|
$-3.20 | $-2.14 | -1.0580 | -49.39% |
Financial Statements
| Revenues | $16.80M |
| Benefits Costs and Expenses | $67.50M |
| Cost Of Revenue | $3.99M |
| Costs And Expenses | $49.23M |
| Gross Profit | $12.81M |
| Nonoperating Income/Loss | -$18.28M |
| Operating Expenses | $45.24M |
| Selling, General, and Administrative Expenses | $42.45M |
| Research and Development | $1.23M |
| Other Operating Expenses | $1.56M |
| Operating Income/Loss | -$32.43M |
| Income/Loss From Continuing Operations After Tax | -$43.32M |
| Income/Loss From Continuing Operations Before Tax | -$50.71M |
| Income Tax Expense/Benefit | -$7.39M |
| Income Tax Expense/Benefit, Current | $0.00 |
| Income Tax Expense/Benefit, Deferred | -$7.39M |
| Net Income/Loss | -$43.32M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$43.32M |
| Net Income/Loss Available To Common Stockholders, Basic | -$43.32M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$23.04 |
| Diluted Earnings Per Share | -$23.04 |
| Basic Average Shares | 1,880,498 |
| Diluted Average Shares | 1,880,498 |
| Assets | $130.40M |
| Current Assets | $53.41M |
| Inventory | $23.57M |
| Other Current Assets | $29.84M |
| Noncurrent Assets | $76.99M |
| Fixed Assets | $9.59M |
| Other Non-current Assets | $67.40M |
| Liabilities | $91.52M |
| Current Liabilities | $25.99M |
| Accounts Payable | $2.99M |
| Wages | $3.48M |
| Other Current Liabilities | $19.53M |
| Noncurrent Liabilities | $65.52M |
| Equity | $38.88M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $38.88M |
| Liabilities And Equity | $130.40M |
| Net Cash Flow From Operating Activities | -$22.59M |
| Net Cash Flow From Operating Activities, Continuing | -$22.59M |
| Net Cash Flow From Investing Activities | -$5.24M |
| Net Cash Flow From Investing Activities, Continuing | -$5.24M |
| Net Cash Flow From Financing Activities | $45.34M |
| Net Cash Flow From Financing Activities, Continuing | $45.34M |
| Net Cash Flow | $17.51M |
| Net Cash Flow, Continuing | $17.51M |
| Comprehensive Income/Loss | -$43.32M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$43.32M |
| Other Comprehensive Income/Loss | -$43.32M |